These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9774594)

  • 1. Development and evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay based on the 18-kilodalton matrix protein for diagnosis of primary EBV infection.
    Chan KH; Luo RX; Chen HL; Ng MH; Seto WH; Peiris JS
    J Clin Microbiol; 1998 Nov; 36(11):3359-61. PubMed ID: 9774594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.
    Fachiroh J; Stevens SJ; Haryana SM; Middeldorp JM
    J Virol Methods; 2010 Oct; 169(1):79-86. PubMed ID: 20621126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection.
    Tranchand-Bunel D; Gras-Masse H; Bourez B; Dedecker L; Auriault C
    J Clin Microbiol; 1999 Jul; 37(7):2366-8. PubMed ID: 10364618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood.
    Schaade L; Kleines M; Häusler M
    J Clin Microbiol; 2001 Nov; 39(11):3902-5. PubMed ID: 11682505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
    Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
    Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
    Radtke M; Gärtner B; Franke D
    Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
    Klutts JS; Liao RS; Dunne WM; Gronowski AM
    J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Epstein-Barr virus-specific antibodies by an automated enzyme immunoassay. Performance evaluation and cost analysis.
    Tang YW; Helgason JA; Wold AD; Smith TF
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):549-54. PubMed ID: 9764394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.
    Casey JL; Coley AM; Street G; Parisi K; Devine PL; Foley M
    J Clin Microbiol; 2006 Mar; 44(3):764-71. PubMed ID: 16517852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enzyme-linked immunosorbent assay for the measurement of human IgA antibody responses to Epstein-Barr virus membrane antigen.
    Durda PJ; Sullivan M; Kieff E; Pearson GR; Rabin H
    Intervirology; 1993; 36(1):11-9. PubMed ID: 8225907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U; Berth M; Lauseker-Hao Y; Meyer-Schlinkmann K; Bohnert M; Jochum S; Schuhmann K
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.
    Binnicker MJ; Jespersen DJ; Harring JA; Rollins LO; Beito EM
    Clin Vaccine Immunol; 2008 Sep; 15(9):1410-3. PubMed ID: 18632919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of an immunofiltration assay detecting IgM antibodies against ZEBRA and viral capsid p18 proteins (Immunoquick(®) filtration EBV M) for the diagnosis of heterophile antibody-negative primary Epstein-Barr virus infection in children.
    Meza LD; Sancho-Tello S; Muñoz-Cobo B; Costa E; Bravo D; Pazos JM; Corrales I; Marcano X; Tohalino M; Navarro D
    J Clin Virol; 2012 Mar; 53(3):270-1. PubMed ID: 22209289
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies.
    Bruu AL; Hjetland R; Holter E; Mortensen L; Natås O; Petterson W; Skar AG; Skarpaas T; Tjade T; Asjø B
    Clin Diagn Lab Immunol; 2000 May; 7(3):451-6. PubMed ID: 10799460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.